Laguilles, Aldwin C.
HRN: 21-32-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/14/2022
05/20/2022
TOPICAL
25gm
BID
Infected Wound Nasal Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes